JUN 13, 2017 9:00 AM PDT

WEBINAR: High content imaging and analysis for drug discovery: phenotypic assays, instrumentation and software

Sponsored by: Thermo Fisher Scientific
Speaker
  • Senior Staff Scientist, Biosciences Division, Thermo Fisher Scientific
    Biography
      Nick received his Ph.D. from the Department of Physiology at the University of Liverpool and completed a post-doctoral fellowship at the NIH. Nick has been with Thermo Fisher Scientific for seven years and is currently a Senior Staff Scientist in Research and Development. He has led the development of over 50 products that cover a diverse range of technology platforms including fluorescent protein-based biosensors, Invitrogen™ Click-iT™ chemistry and environmentally sensitive dyes.

    Abstract

    EVENT DETAILS: 

    DATE: June 13, 2017
    TIME: 9:00am PT, 12:00pm ET

    Thermo Fisher Scientific is proud to present the SyncD3 webinar series.  As a thought-leader in science our first commitment is to you the scientist and partnering to drive the conversation on current practices, standards and the development of innovation. 

    Join us for our continuation of the SyncD3 webinar series and virtual event, where we will discuss cutting-edge tools and topics in the field(s) of Drug Discovery & Development such as:

    • HCS/Phenotypic Assays
    • Functional Genomics & Drug Metabolism
    • 3D models/Organoids
    • Diseased models
    • CRISPR
    • Stem Cells

    We will discuss where these areas intersect and impact drug discovery and development and the future of the industry during a live panel discussion with our presenters and you the audience.  Learn from real field scientists and researchers who are working in the ADME/Tox and Drug Discovery fields and bring your questions for the open forum Q&A session after our presentations. 

    If you cannot make the live presentation you are always capable of accessing the recorded information, presentations and Q&A any time after the event by registering here.

    High content imaging and analysis for drug discovery: phenotypic assays, instrumentation and software

    High content imaging and analysis offers a robust, high throughput analysis of large numbers of cells with the benefit of the spatial and temporal demarcation afforded by fluorescence microscopy. This seminar will provide an overview of high content imaging platforms, the fluorescent labels required to automate the segmentation of cells and their subcellular domains as well as newly developed fluorescent assays from Thermo Fisher Scientific with an emphasis on those that provide an indication of cell viability, mechanisms of cell death, proliferation as well as the plethora of reagents that can be used to indicate pre-lethal toxicity.  Newly developed phenotypic assays, in particular those used to profile CRISPR-Cas9 edited cells will be discussed. Novel probes and labeling approaches to report internalization of ligands and therapeutic antibodies will also be presented with reference to high content imaging.  


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    JUN 13, 2017 9:00 AM PDT

    WEBINAR: High content imaging and analysis for drug discovery: phenotypic assays, instrumentation and software

    Sponsored by: Thermo Fisher Scientific

    Specialty

    Cell Biology

    Cancer Research

    Molecular Biology

    Biotechnology

    Immunology

    Cell Culture

    Drug Discovery

    Biochemistry

    Molecular Diagnostics

    Clinical Research

    Assay Development

    Biomarkers

    Microbiology

    Laboratory Testing

    Genetics

    Geography

    North America52%

    Europe27%

    Asia12%

    South America3%

    Oceania2%

    Africa2%

    Registration Source

    Website Visitors100%

    Job Title

    Student17%

    Research Scientist16%

    Scientist16%

    Executive15%

    Facility/Department Manager11%

    Educator/Faculty6%

    Post Doc5%

    Medical Doctor/Specialist5%

    Lab Management3%

    Marketing/Sales3%

    Clinical Laboratory Scientist2%

    Medical Laboratory Technician1%

    Consultant1%

    Organization

    Academic Institution13%

    Biotech Company10%

    Research Institute6%

    Life Science Company4%

    Contract Research Organization (Cro)2%

    Medical School2%

    Pharmaceutical Company2%

    Non-Profit Organization2%

    Industrial Company2%

    Clinical Laboratory2%

    Government1%

    Hospital1%

    Consultant1%

    Medical Device Company1%

    Other5%


    Show Resources
    Loading Comments...
    Show Resources